These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2706320)

  • 1. Sustained release properties of the once daily theophylline capsule BY912 as compared with Theo-24 capsules.
    Jonkman JH; Steinijans VW; Beier W; van der Boon WJ; Crasmeijer G
    Biopharm Drug Dispos; 1989; 10(2):213-24. PubMed ID: 2706320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theophylline absorption from sustained-release products: comparative steady-state bioavailability of once-daily Theo-Dur, Theo-24, and Uniphyl.
    Hurwitz A; Karim A; Burns TS
    J Clin Pharmacol; 1987 Nov; 27(11):855-61. PubMed ID: 3429692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of a new sustained-release theophylline capsule in fasted and non-fasted healthy subjects: single and multiple dosing studies.
    West RJ; Boehm G; Dwyer M; Williams DB; Sansom LN; Penna AC
    Biopharm Drug Dispos; 1990 Mar; 11(2):165-77. PubMed ID: 2328301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of four slow-release theophylline formulations in the beagle dog.
    Koritz GD; McKiernan BC; Neff-Davis CA; Munsiff IJ
    J Vet Pharmacol Ther; 1986 Sep; 9(3):293-302. PubMed ID: 3761420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily dosing of a new ultrasustained-release theophylline preparation.
    Van den Brande P; Nys J; Tjandramaga TB; Verhelst F; Demedts M
    Respiration; 1987; 52(2):144-53. PubMed ID: 3671893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.
    Steinijans VW; Sauter R; Böhm A; Staudinger H
    Arzneimittelforschung; 1988 Aug; 38(8A):1241-50. PubMed ID: 3190813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium.
    Rojanasthien N; Kovjiriyapan K; Manorot M; Pothirat C
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):69-78. PubMed ID: 11699723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring.
    Rogers RJ; Wiener MB; Hill MR; Szefler SJ
    Am Rev Respir Dis; 1987 Nov; 136(5):1168-73. PubMed ID: 3674579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.
    Weinberger MM
    Pharmacotherapy; 1984; 4(4):181-98. PubMed ID: 6483637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a new sustained-release theophylline preparation, TheoBeads, with Theo-Dur tablets in children with asthma.
    Welch MJ; Orgel HA; Meltzer EO; Kemp JP; Gawchik S; Rooklin AR; Tinkelman DG
    J Asthma; 1988; 25(5):269-74. PubMed ID: 3182591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative bioavailability and bioequivalence study of theophylline sustained release formulations.
    Vergin H; Mahr G; Winterhalter B; Wigand R
    Arzneimittelforschung; 2003; 53(9):635-9. PubMed ID: 14558437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison study of sustained-release theophylline products: Slo-bid capsules versus Theo-Dur tablets in 20 children and young adults with asthma.
    Hannaway PJ; Hopper GD
    J Allergy Clin Immunol; 1986 Mar; 77(3):456-64. PubMed ID: 3512663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption properties of two theophylline sustained-release products in smokers.
    Miller R; Rheeders M
    S Afr Med J; 1984 Jun; 65(26):1045-8. PubMed ID: 6740419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in vitro dissolution properties and in vivo steady-state pharmacokinetics of two sustained-release theophylline preparations.
    Jonkman JH; Van der Boon WJ; Grasmeijer G
    Pharm Weekbl Sci; 1988 Feb; 10(1):17-21. PubMed ID: 3353206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative bio-availability of theophylline whole and halved sustained-release tablets.
    Müller FO; Hundt HK; Luus HG; van Dyk M; Groenewoud G; van der Meer MJ; Steinijans VW
    S Afr Med J; 1987 Aug; 72(3):175-8. PubMed ID: 3299763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained-release theophylline pharmacokinetics in the cat.
    Dye JA; McKiernan BC; Jones SD; Neff-Davis CA; Koritz GD
    J Vet Pharmacol Ther; 1989 Jun; 12(2):133-40. PubMed ID: 2746720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
    Götz J; Sauter R; Steinijans VW; Jonkman JH
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men.
    Dockhorn RJ; Cefali EA; Straughn AB
    Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.